| 6TCU: reference: Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model., Prati F, Buonfiglio R, Furlotti G, Cavarischia C, Mangano G, Picollo R, Oggianu L, di Matteo A, Olivieri S, Bovi G, Porceddu PF, Reggiani A, Garrone B, Di Giorgio FP, Ombrato R, ACS Med Chem Lett. 2020 Mar 24;11(5):825-831. doi:, 10.1021/acsmedchemlett.9b00633. eCollection 2020 May 14. PMID: 32435391 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).